A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study
Clinical trial NCT04412291 · UNKNOWN
Trial details
- NCT number
- NCT04412291
- Sponsor
- Karolinska University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-11
- Primary completion
- 2021-03-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.